1,628
Views
1
CrossRef citations to date
0
Altmetric
Clinical Study

Mineral and bone disorder after kidney transplantation: a single-center cohort study

, , , , , , , , , , , , , , , & show all
Article: 2210231 | Received 08 Dec 2022, Accepted 28 Apr 2023, Published online: 15 May 2023

References

  • Garcia GG, Harden PN, Chapman JR, World Kidney Day Steering Committee 2012 The global role of kidney transplantation. Am J Hypertens. 2012;25(3):1–11.
  • Hirukawa T, Kakuta T, Nakamura M, et al. Mineral and bone disorders in kidney transplant recipients: reversible, irreversible, and de novo abnormalities. Clin Exp Nephrol. 2015;19(4):543–555.
  • Zhao X, Niu Q, Gan L, et al. Baseline data report of the China dialysis outcomes and practice patterns study (DOPPS). Sci Rep. 2021;11(1):873.
  • Cannata-Andia JB, Martin-Carro B, Martin-Virgala J, et al. Chronic kidney Disease-Mineral and bone disorders: pathogenesis and management. Calcif Tissue Int. 2021;108(4):410–422.
  • Economidou D, Dovas S, Papagianni A, et al. FGF-23 levels before and after renal transplantation. J Transplant. 2009;2009:379082.
  • Evenepoel P, Meijers BK, de Jonge H, et al. Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation. Clin J Am Soc Nephrol. 2008;3(6):1829–1836.
  • Kawarazaki H, Shibagaki Y, Fukumoto S, et al. Natural history of mineral and bone disorders after living-donor kidney transplantation: a one-year prospective observational study. Ther Apher Dial. 2011;15(5):481–487.
  • Evenepoel P. Recovery versus persistence of disordered mineral metabolism in kidney transplant recipients. Semin Nephrol. 2013;33(2):191–203.
  • Naylor KL, Li AH, Lam NN, et al. Fracture risk in kidney transplant recipients: a systematic review. Transplantation. 2013;95(12):1461–1470.
  • Nair SS, Lenihan CR, Montez-Rath ME, et al. Temporal trends in the incidence, treatment and outcomes of hip fracture after first kidney transplantation in the United States. Am J Transplant. 2014;14(4):943–951.
  • Wolf M, Weir MR, Kopyt N, et al. A prospective cohort study of mineral metabolism after kidney transplantation. Transplantation. 2016;100(1):184–193.
  • Keronen S, Martola L, Finne P, et al. Changes in bone histomorphometry after kidney transplantation. Clin J Am Soc Nephrol. 2019;14(6):894–903.
  • Meneghini M, Regalia A, Alfieri C, et al. Calcium and osteoprotegerin levels predict the progression of the abdominal aortic calcifications after kidney transplantation. Transplantation. 2013;96(1):42–48.
  • Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO study group. Osteoporos Int. 1994;4(6):368–381.
  • Leib ES, Lewiecki EM, Binkley N, et al. Official positions of the international society for clinical densitometry. J Clin Densitom. 2004;7(1):1–6.
  • Jorgensen HS, Behets G, Bammens B, et al. Natural history of bone disease following kidney transplantation. J Am Soc Nephrol. 2022;33(3):638–652.
  • Ferreira AC, Mendes M, Silva C, et al. Improvement of mineral and bone disorders after renal transplantation. Transplantation. 2022;106(5):e251–e261.
  • Altman AM, Sprague SM. Mineral and bone disease in kidney transplant recipients. Curr Osteoporos Rep. 2018;16(6):703–711.
  • Taniguchi M, Tokumoto M, Matsuo D, et al. Persistent hyperparathyroidism in renal allograft recipients: vitamin D receptor, calcium-sensing receptor, and apoptosis. Kidney Int. 2006;70(2):363–370.
  • Evenepoel P, Cavalier E, D’Haese PC. Bone biomarkers in de novo renal transplant recipients. Clin Chim Acta. 2020;501:179–185.
  • Chen DC, Liao EY, Xu L, et al. Guidelines for clinical application of biochemical markers of bone metabolism. Chinese Journal of Osteoporosis and Bone Mineral Research. 2015;8(04):283–293.
  • Evenepoel P, Claes K, Meijers B, et al. Natural history of mineral metabolism, bone turnover and bone mineral density in de novo renal transplant recipients treated with a steroid minimization immunosuppressive protocol. Nephrol Dial Transplant. 2020;35(4):697–705.
  • Jorgensen HS, Behets G, Bammens B, et al. Patterns of renal osteodystrophy 1 year after kidney transplantation. Nephrol Dial Transplant. 2021;36(11):2130–2139.
  • Li N, Wang MJ, Guo WP, et al. Clinical study on changes of mineral and bone metabolism before and after renal transplantation. Chin J Organ Transplant. 2016;37(11):647–652.
  • Evenepoel P, Claes K, Meijers B, et al. Bone mineral density, bone turnover markers, and incident fractures in de novo kidney transplant recipients. Kidney Int. 2019;95(6):1461–1470.
  • Brandenburg VM, Politt D, Ketteler M, et al. Early rapid loss followed by long-term consolidation characterizes the development of lumbar bone mineral density ­after kidney transplantation. Transplantation. 2004;77(10):1566–1571.
  • Zisman AL, Sprague SM. Bone disease after kidney transplantation. Adv Chronic Kidney Dis. 2006;13(1):35–46.
  • Boonen S, Pye SR, O’Neill TW, et al. Influence of bone remodelling rate on quantitative ultrasound parameters at the calcaneus and DXA BMDa of the hip and spine in Middle-aged and elderly european men: the european male ageing study (EMAS). Eur J Endocrinol. 2011;165(6):977–986.
  • Iyer SP, Nikkel LE, Nishiyama KK, et al. Kidney transplantation with early corticosteroid withdrawal: paradoxical effects at the Central and peripheral skeleton. J Am Soc Nephrol. 2014;25(6):1331–1341.
  • Canalis E, Mazziotti G, Giustina A, et al. Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int. 2007;18(10):1319–1328.
  • Farmer CK, Hampson G, Abbs IC, et al. Late low-dose steroid withdrawal in renal transplant recipients increases bone formation and bone mineral density. Am J Transplant. 2006;6(12):2929–2936.
  • Liu LS, Liu YF, Deng RH, et al. Clinical study on withdrawal of corticosteroids in stable recipients after renal transplantation. Chinese Journal of Organ Transplantation. 2013;34(11):643–646.
  • Blaslov K, Katalinic L, Kes P, et al. What is the impact of immunosuppressive treatment on the post-transplant renal osteopathy? Int Urol Nephrol. 2014;46(5):1019–1024.
  • Bozkaya G, Nart A, Uslu A, et al. Impact of calcineurin inhibitors on bone metabolism in primary kidney transplant patients. Transplant Proc. 2008;40(1):151–155.
  • Kneissel M, Luong-Nguyen NH, Baptist M, et al. Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts. Bone. 2004;35(5):1144–1156.
  • Saoji R, Das RS, Desai M, et al. Association of high-density lipoprotein, triglycerides, and homocysteine with bone mineral density in young indian tribal women. Arch Osteoporos. 2018;13(1):108.
  • Jeong IK, Cho SW, Kim SW, et al. Lipid profiles and bone mineral density in pre- and postmenopausal women in korea. Calcif Tissue Int. 2010;87(6):507–512.
  • Wen D, Androjna C, Vasanji A, et al. Lipids and collagen matrix restrict the hydraulic permeability within the porous compartment of adult cortical bone. Ann Biomed Eng. 2010;38(3):558–569.